Viral nanotechnology, immunotherapy, drug delivery, imaging
About
At UC San Diego, Nicole Steinmetz leads a translational nanomedicine program using plant-derived viral nanoparticles for immunotherapy, delivery, and imaging. With major NIH/NCI support, her team advances in situ vaccination via canine studies, GMP manufacturing, and slow‑release devices toward human trials.